Melanoma - Current Clinical Management and Future Therapeutics 2015
DOI: 10.5772/59176
|View full text |Cite
|
Sign up to set email alerts
|

Gangliosides and Antigangliosides in Malignant Melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 106 publications
0
4
0
Order By: Relevance
“…The present study showed no significant increase in quantitative determination of TuM2-PK in patients with T1N0Mo ccRCC compared with healthy subjects. The plasmatic level of TuM2-PK in patients with ccRCC was correlated with IL-8 levels, data that suggest a possible interaction between these markers and tumoral neoangiogensis [101][102][103][104][105][106]. A recent report showed that the extracellular level of TuM2-PK in patients with localized renal cell carcinoma was 3.2-fold lower compared with patients with disseminated disease [107].…”
Section: Discussionmentioning
confidence: 95%
“…The present study showed no significant increase in quantitative determination of TuM2-PK in patients with T1N0Mo ccRCC compared with healthy subjects. The plasmatic level of TuM2-PK in patients with ccRCC was correlated with IL-8 levels, data that suggest a possible interaction between these markers and tumoral neoangiogensis [101][102][103][104][105][106]. A recent report showed that the extracellular level of TuM2-PK in patients with localized renal cell carcinoma was 3.2-fold lower compared with patients with disseminated disease [107].…”
Section: Discussionmentioning
confidence: 95%
“…The hypoxic microenvironment constitutes a developing area of investigation in solid tumours. Several studies have identified various soluble factors (such as different interleukins) in the neoplastic microenvironment involved in cancer development and progression (4)(5)(6)13,16,17,(26)(27)(28)(29). The current study explored the contribution of the angiogenic response to hypoxia and inflammation in PCa and BPH biology.…”
Section: Discussionmentioning
confidence: 99%
“…They can act as receptors and various biological substances, contributing to the expression of immune cell functions. Accordingly, the possibility of their application for treating prostate cancer, 23 melanoma, 24 and diabetic nephropathy 25 has been suggested, and related research is being actively conducted. According to Nicolae et al., titers of anti-GDA1a and antiGQ1b (ganglioside antibodies) were higher in patients with BPH than in controls.…”
Section: Discussionmentioning
confidence: 99%